Lymphedema is a common complication of breast cancer treatment. Yoga is a nonconventional and noninvasive intervention that is reported to show beneficial effects in patients with breast cancer-related lymphedema (BCRL). This study attempted to systematically review the effect of yoga therapy on managing lymphedema, increasing the range of motion (ROM), and quality of life (QOL) among breast cancer survivors. The review search included studies from electronic bibliographic databases, namely Medline (PubMed), Embase, and Google Scholar till June 2019. Studies which assessed the outcome variables such as QOL and management of lymphedema or related physical symptoms as effect of yoga intervention were considered for review. Two authors individually reviewed, selected according to Cochrane guidelines, and extracted the articles using Covidence software. Screening process of this review resulted in a total of seven studies. The different styles of yoga employed in the studies were Iyengar yoga ( n = 2), Satyananda yoga ( n = 2), Hatha yoga ( n = 2), and Ashtanga yoga ( n = 1). The length of intervention and post intervention analysis ranged from 8 weeks to 12 months. Four studies included home practice sessions. QOL, ROM, and musculoskeletal symptoms showed improvement in all the studies. Yoga could be a safe and feasible exercise intervention for BCRL patients. Evidence generated from these studies was of moderate strength. Further long-term clinical trials with large sample size are essential for the development and standardization of yoga intervention guidelines for BCRL patients.

This study aimed to assess the feasibility of personalized yoga therapy intervention in a private setting and its effect on quality of life (QOL), sleep quality, and symptom relief among patients with multiple sclerosis (MS). A single-group pre- and post-experimental study was conducted among 10 members of the Multiple Sclerosis Society of India between December 2017 and April 2018. At baseline and during follow-up, QOL, sleep quality, symptoms, and pain were assessed using the Multiple Sclerosis Quality of Life, Pittsburgh Sleep Quality Index, MS Symptom Checklist, and visual analogue scale, respectively. The intervention comprised 12 private customized yoga sessions of 1 hour duration and three group sessions, all spread over 3-months. Patient feedback and direct observations by the yoga therapist we re documented at each session. Ten patients (seven female, three male, age 31–52 years) were enrolled in the yoga intervention; seven completed 8–12 sessions, and three completed fewer than 5 sessions. Therapist-to-patient ratio was 1:2. All domains except sexual function showed clinically significant improvement in QOL scores. Statistically significant improvement was found in social function (p = 0.014) and change in health status (p = 0.029) scores after the intervention. Although there was improvement in pain and sleep quality, these changes were not statistically significant. Patients reported improvement in symptoms with practice of yoga alongside lifestyle changes. The study supports the feasibility of this 3-month yoga intervention for patients with MS. Studies with larger sample sizes are required to confirm our findings.

No abstract